Lateral Cervical Node Dissection in Differentiated Thyroid Cancer.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorCentro de Excelencia en Enfermedades de Cabeza y Cuello

About this trial

The objective of this study is to compare shoulder and neck morbidity and the effectiveness of cervical lateral nodal dissection in patients with differentiated thyroid cancer and lateral metastases between the anterior and posterior approaches to the sternocleidomastoid muscle (SCM)

Eligibility criteria

Qualifiers

Patients ≥ 18 years.

Patients with macroscopic lymph node involvement identified by physical examination, imaging or intraoperatively in lateral neck.

Patients with microscopic nodal involvement confirmed by FNAB (definition by the pathologist of suspected or confirmed metastatic papillary carcinoma according to the Bethesda criteria)

Candidates for lateral lymph node dissection due to suspected or confirmed disease metastatic lymph nodes as defined by the treating surgeon.

Disqualifiers

Patients with a history of previous neck dissection

Histological confirmation of medullary or anaplastic carcinoma

Previous spinal nerve injury

Trial design

Treatments tested in this trial

  • Traditional neck dissection approach
  • Anterior neck dissection approach

Treatment groups

62 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Centro de Excelencia en Enfermedades de Cabeza y Cuello

Lead sponsor

Hospital Alma Mater de Antioquia

Collaborator

Hospital San Vicente Fundación

Collaborator

Clinica Las Vegas- Grupo QuironSalud

Collaborator